Centrus IPO Presentation Deck

America's Nuclear Fuel Technology Company Globally Recognized Supplier of Low-Enriched Uranium (LEU) Fuel 40% global growth in nuclear forecasted by 2040* - Broad supply base provides ability to opportunistically improve supply options based on conditions in the market Long-time supplier to utilities in North America, Asia, and Europe World-class Technical, Engineering, and Manufacturing Capabilities Building the only US uranium enrichment plant licensed to produce HALEU (High-Assay, Low Enriched Uranium) via a $115M cost-share contract - Fuel can be used with existing and next-generation reactors and meets US national security requirements for uranium enrichment - Platform for growth and diversification in areas around manufacturing, fuel, and decommissioning and decontamination services (D&D) Centrus Strong Financial Performance and Cash Flows Consistent cash flow built on $1 billion long-term order book through the end of the decade, including $30+M TTM EBITDA Clear visibility on 2020-2022 that supports continued financial performance * International Atomic Energy Agency Centrus Proprietary Information

View entire presentation